Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Keratosis, Actinic 1Carcinoma, Basal Cell 1

Interventions

Nivolumab 4Biopsy 4Specimen Handling 3Ipilimumab 3CTLA-4 Antigen 3prednylidene 2deltacortene 2Prednisone 2Magnetic Resonance Spectroscopy 2Imiquimod 2Celecoxib 2talimogene laherparepvec 1endonuclease V, phage T4 1Tacrolimus 1Sirolimus 1Microarray Analysis 1Isotretinoin 1Deoxyribonuclease (Pyrimidine Dimer) 1Chemoprevention 1Biological Therapy 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Carcinoma, Basal Cell × endonuclease V, phage T4 × Clear all
NCT00089180 2015-12-04

T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant

National Cancer Institute (NCI)

Phase 2 Completed
100 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡